End-of-day quote
Johannesburg S.E.
06:00:00 2024-05-07 pm EDT
|
5-day change
|
1st Jan Change
|
94.85
ZAR
|
-0.32%
|
|
+1.00%
|
-13.53%
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
11,764
|
12,314
|
9,243
|
11,574
|
10,008
|
-
|
-
|
Enterprise Value (EV)
1 |
11,764
|
12,314
|
14,588
|
11,574
|
11,617
|
9,849
|
7,633
|
P/E ratio
|
-
|
10.1
x
|
9.98
x
|
9.86
x
|
6.56
x
|
5.13
x
|
4.26
x
|
Yield
|
5.33%
|
-
|
8.84%
|
-
|
3.6%
|
6.2%
|
7.59%
|
Capitalization / Revenue
|
0.47
x
|
0.47
x
|
0.26
x
|
0.31
x
|
0.26
x
|
0.25
x
|
0.23
x
|
EV / Revenue
|
0.47
x
|
0.47
x
|
0.41
x
|
0.31
x
|
0.3
x
|
0.24
x
|
0.18
x
|
EV / EBITDA
|
3.54
x
|
-
|
4.09
x
|
3.14
x
|
2.9
x
|
2.2
x
|
1.52
x
|
EV / FCF
|
-
|
-
|
-6.53
x
|
-
|
4.84
x
|
5.37
x
|
3.18
x
|
FCF Yield
|
-
|
-
|
-15.3%
|
-
|
20.7%
|
18.6%
|
31.5%
|
Price to Book
|
-
|
-
|
-
|
-
|
0.73
x
|
0.67
x
|
-
|
Nbr of stocks (in thousands)
|
109,944
|
109,944
|
105,518
|
105,518
|
105,518
|
-
|
-
|
Reference price
2 |
107.0
|
112.0
|
87.60
|
109.7
|
94.85
|
94.85
|
94.85
|
Announcement Date
|
2/25/20
|
3/2/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
24,799
|
26,053
|
35,583
|
37,500
|
38,446
|
40,546
|
42,953
|
EBITDA
1 |
3,326
|
-
|
3,570
|
3,683
|
4,005
|
4,485
|
5,023
|
EBIT
1 |
2,031
|
-
|
2,047
|
2,571
|
2,942
|
3,403
|
3,925
|
Operating Margin
|
8.19%
|
-
|
5.75%
|
6.86%
|
7.65%
|
8.39%
|
9.14%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
1,759
|
-
|
2,556
|
3,123
|
3,729
|
Net income
1 |
-
|
-
|
959
|
-
|
1,561
|
2,002
|
2,423
|
Net margin
|
-
|
-
|
2.7%
|
-
|
4.06%
|
4.94%
|
5.64%
|
EPS
2 |
-
|
11.12
|
8.780
|
11.12
|
14.46
|
18.48
|
22.28
|
Free Cash Flow
1 |
-
|
-
|
-2,235
|
-
|
2,401
|
1,833
|
2,402
|
FCF margin
|
-
|
-
|
-6.28%
|
-
|
6.25%
|
4.52%
|
5.59%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
59.95%
|
40.87%
|
47.82%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
153.85%
|
91.54%
|
99.1%
|
Dividend per Share
2 |
5.700
|
-
|
7.740
|
-
|
3.410
|
5.880
|
7.195
|
Announcement Date
|
2/25/20
|
3/2/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 S1
|
---|
Net sales
1 |
18,404
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
|
-
|
Net margin
|
-
|
EPS
2 |
5.960
|
Dividend per Share
|
-
|
Announcement Date
|
7/26/23
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
5,345
|
-
|
1,609
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
159
|
2,375
|
Leverage (Debt/EBITDA)
|
-
|
-
|
1.497
x
|
-
|
0.4017
x
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-2,235
|
-
|
2,401
|
1,833
|
2,402
|
ROE (net income / shareholders' equity)
|
12.1%
|
-
|
-
|
-
|
11.1%
|
12.5%
|
13.3%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
-
|
-
|
129.0
|
142.0
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
833
|
-
|
1,552
|
-
|
1,319
|
1,373
|
1,428
|
Capex / Sales
|
3.36%
|
-
|
4.36%
|
-
|
3.43%
|
3.39%
|
3.32%
|
Announcement Date
|
2/25/20
|
3/2/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Last Close Price
94.85
ZAR Average target price
124
ZAR Spread / Average Target +30.73% Consensus |
1st Jan change
|
Capi.
|
---|
| -13.53% | 544M | | +17.59% | 66.51B | | +0.84% | 48.47B | | +17.11% | 41.43B | | +22.90% | 27.19B | | +11.45% | 19.82B | | +5.08% | 18.15B | | -21.31% | 15.98B | | +4.38% | 15.53B | | -9.70% | 15.46B |
Other Specialty Chemicals
|